Placemark Investments, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Placemark Investments, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2014$1,275,000
+3.8%
34,092
-3.1%
0.02%0.0%
Q3 2014$1,228,000
-13.0%
35,176
-12.1%
0.02%
-8.0%
Q2 2014$1,411,000
+10.7%
40,021
+2.3%
0.02%
+4.2%
Q1 2014$1,275,000
-38.0%
39,116
-19.8%
0.02%
-29.4%
Q4 2013$2,056,000
-4.6%
48,791
-9.7%
0.03%
-17.1%
Q3 2013$2,155,000
+0.5%
54,057
+4.3%
0.04%
-10.9%
Q2 2013$2,145,00051,8500.05%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders